BPI Labs LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 12393 S Belcher Rd, Ste 450, Largo, Florida (FL) 33773, United States (USA)
- Operations here
- analysislabelmanufacture
- FDA identifiers
- FEI 3015156709 · DUNS 078627620
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBioresearch Monitoring2025-04-23
- NAIDrug Quality Assurance2025-02-21
Drugs this plant is listed as making
12 distinct drugs across 21 products name this site in their FDA label.
- AlcoholAjenat Pharmaceuticals LLC
- Aminocaproic acidBpi Labs Llc
- EpinephrineBPI Labs, LLC
- FluoresceinBPI Labs LLC
- Hyoscyamine SulfateBPI Labs LLC
- Methylene BlueBpi Labs Llc
- Naloxone HydrochlorideBPI Labs LLC
- Papaverine HydrochlorideBPI Labs LLC
- Phenobarbital SodiumBPI Labs LLC
- Potassium Chloride for Oral SolutionBPI Labs LLC
- TacrolimusBPI Labs LLC
- Tetracaine HCLBpi Labs Llc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.